Session » Abstracts: Epidemiology & Public Health I
- 3:00PM-4:30PM
-
Abstract Number: 0844
Effectiveness and Safety of the Recombinant Zoster Vaccine in Patients ≥18 Years of Age with Systemic Lupus Erythematosus or Multiple Sclerosis
- 3:00PM-4:30PM
-
Abstract Number: 0843
External Validation and Extension of Population-Based Systemic Lupus Erythematosus Risk Prediction Models Using Genetics, and Lifestyle and Environmental Factors
- 3:00PM-4:30PM
-
Abstract Number: 0848
Impact of SGLT2i Initiation on the Need for Urate-Lowering Therapy and Colchicine Among Gout Patients with Type 2 Diabetes:Propensity-Score Matched, Active Comparator, New User Design Study
- 3:00PM-4:30PM
-
Abstract Number: 0847
Sex and Race-Specific Distributions in Medial Fixed Joint Space Width in Healthy Knees from Three Longitudinal Cohorts
- 3:00PM-4:30PM
-
Abstract Number: 0846
Three Novel Metabolomic Signatures of Inflammation for Female Gout Risk: A Prospective Cohort Study over 26 Years